FDA Inspection 1222369 — LifeShare Blood Centers

LifeShare Blood Centers — FEI 3005241159

The FDA completed an inspection of LifeShare Blood Centers on October 26, 2023 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 26, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Baton Rouge, LA (United States)